The board shall administer this part 2 and the general assembly, by bill, may add substances to or delete or reschedule substances listed in section 18-18-203, 18-18-204, 18-18-205, 18-18-206, or 18-18-207. Source: L. 92: Entire article R&RE, p. 332, § 1, effective July 1. Editor’s note: This section is similar to former § 12-22-103 as […]
The controlled substances listed in or to be added to the schedules in sections 18-18-203, 18-18-204, 18-18-205, 18-18-206, and 18-18-207 are listed or added by any official, common, usual, chemical, or trade name used. Source: L. 92: Entire article R&RE, p. 332, § 1, effective July 1.
A substance shall be added to schedule I by the general assembly when: The substance has high potential for abuse; The substance has no currently accepted medical use in treatment in the United States; and The substance lacks accepted safety for use under medical supervision. Unless specifically excepted by Colorado or federal law or Colorado […]
A substance shall be added to schedule II by the general assembly when: The substance has high potential for abuse; The substance has currently accepted medical use in treatment in the United States, or currently accepted medical use with severe restrictions; and The abuse of the substance may lead to severe psychological or physical dependence. […]
A substance shall be added to schedule III by the general assembly when: The substance has a potential for abuse less than the substances included in schedules I and II; The substance has currently accepted medical use in treatment in the United States; and The abuse of the substance may lead to moderate or low […]
A substance shall be added to schedule IV by the general assembly when: The substance has a low potential for abuse relative to substances included in schedule III; The substance has currently accepted medical use in treatment in the United States; and The abuse of the substance may lead to limited physical dependence or psychological […]
A substance shall be added to schedule V by the general assembly when: The substance has a low potential for abuse relative to substances included in schedule IV; The substance has currently accepted medical use in treatment in the United States; and The abuse of the substance may lead to limited physical dependence or psychological […]
